Bobby Q. Lanier

4.8k citations
31 papers · 3.4k indexed · 2 hit papers · h-index 16
Topics
Asthma and respiratory diseases (24 papers)Allergic Rhinitis and Sensitization (19 papers)Respiratory and Cough-Related Research (8 papers)

In The Last Decade

Bobby Q. Lanier

29 papers receiving 3.2k citations

Hit Papers

Revised nomenclature for allergy for global use: Report o...20012026200920172004200150010001.5k

Peers

Bobby Q. Lanier
Comparison fields: 5 of 114
  • Immunology and Allergy 2.2k
  • Physiology 2.1k
  • Pulmonary and Respiratory Medicine 933
  • Dermatology 818
  • Immunology 411
Replace Ioana Agache with:
Ioana Agache Romania
Dana Wallace United States
M. L. Kowalski Poland
Stanley M. Fìneman United States
Roy Gerth van Wijk Netherlands
Mark S. Dykewicz United States
Enrico Compalati Italy
Pakit Vichyanond Thailand
Pedro Giavina‐Bianchi Brazil
Guy A. Settipane United States
Bobby Q. Lanier relative to Ioana Agache Romania Ioana Agache's profile →
Citations per field
00.5×1.5×
Ioana Agache · 1×
Citations per year

Countries citing papers authored by Bobby Q. Lanier

Since Specialization
Citations

This map shows the geographic impact of Bobby Q. Lanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby Q. Lanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby Q. Lanier more than expected).

Fields of papers citing papers by Bobby Q. Lanier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobby Q. Lanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby Q. Lanier. The network helps show where Bobby Q. Lanier may publish in the future.

Co-authorship network of co-authors of Bobby Q. Lanier

This figure shows the co-authorship network connecting the top 25 collaborators of Bobby Q. Lanier. A scholar is included among the top collaborators of Bobby Q. Lanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bobby Q. Lanier. Bobby Q. Lanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 1
3 36
4 41
5 1
6 26
7 1
8 9
9 43
10 75
11 9
12 117
13 75
14
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003breakdown →
1588
15 34
16 12
17 149
18 1
19 23
20
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmabreakdown →
978

About Bobby Q. Lanier

Bobby Q. Lanier is a scholar working on Immunology and Allergy, Physiology and Dermatology, having authored 31 papers that have together received 3.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (24 papers), Allergic Rhinitis and Sensitization (19 papers) and Respiratory and Cough-Related Research (8 papers). The work is most often cited by research in Immunology and Allergy (2.2k citations), Dermatology (818 citations) and Physiology (2.1k citations). Bobby Q. Lanier has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Angel FowlerTaylor, Jonathan Corren, Niroo Gupta, Thomas A.E. Platts‐Mills, C. Motala, Thomas Bieber, Johannes Ring, Ronald Dahl, William W. Busse and Richard F. Lockey. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Clinical & Experimental Allergy and Otolaryngology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026